Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression

Translational Psychiatry

Volumn 3, Issue , 2013, Pages

  Ancelin, M L ^a,b   Carriere I ^a,b   Scali, J ^a,b   Ritchie, K ^a,b,c   Chaudieu, I ^a,b   Ryan, J ^a,b,d,e  

^a Montpellier 1 University   (France)

^b UNIV MONTPELLIER   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin converting enzyme; Cortisol; Elderly; HPA axis; Late life depression; Prospective study

Indexed keywords

ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROCORTISONE;

AGED; ANGIOTENSIN CONVERTING ENZYME GENE; ARTICLE; CONTROLLED STUDY; DSM-IV; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERVIEW; LATE LIFE DEPRESSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; CIRCADIAN RHYTHM; DEPRESSION; GENETIC PREDISPOSITION; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MULTIVARIATE ANALYSIS; ONSET AGE; SECRETION (PROCESS); STATISTICAL MODEL; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 84890905619     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.95     Document Type: Article

References (59)

1. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res 2006; 98: 1123-1133.
2. Armando I, Volpi S, Aguilera G, Saavedra JM. Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res 2007; 1142: 92-99.
3. Pavlatou MG, Mastorakos G, Lekakis I, Liatis S, Vamvakou G, Zoumakis E et al. Chronic administration of an angiotensin II receptor antagonist resets the hypothalamic-pituitary-adrenal (HPA) axis and improves the affect of patients with diabetes mellitus type 2: preliminary results. Stress 2008; 11: 62-72.
4. Lloyd RB, Nemeroff CB. The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications. Curr Top Med Chem 2011; 11: 609-617.
5. Beluche I, Chaudieu I, Norton J, Carriere I, Boulenger JP, Ritchie K et al. Persistence of abnormal cortisol levels in elderly persons after recovery from major depression. J Psychiatr Res 2009; 43: 777-783.
6. Bhagwagar Z, Cowen PJ. 'It's not over when it's over': persistent neurobiological abnormalities in recovered depressed patients. Psychol Med 2008; 38: 307-313.
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
8. Lei H, Day IN, Vorechovsky I. Exonization of AluYa5 in the human ACE gene requires mutations in both 30 and 50 splice sites and is facilitated by a conserved splicing enhancer. Nucleic Acids Res 2005; 33: 3897-3906.
9. Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008; 13: 772-785.
10. Wu Y, Wang X, Shen X, Tan Z, Yuan Y. The I/D polymorphism of angiotensinconverting enzyme gene in major depressive disorder and therapeutic outcome: a case-control study and meta-analysis. J Affect Disord 2012; 136: 971-978.
11. Bleumink GS, Schut AF, Sturkenboom MC, Deckers JW, van Duijn CM, Stricker BH. Genetic polymorphisms and heart failure. Genet Med 2004; 6: 465-474.
12. Baghai TC, Binder EB, Schule C, Salyakina D, Eser D, Lucae S et al. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry 2006; 11: 1003-1015.
13. Angunsri R, Sritharathikhun T, Suttirat S, Tencomnao T. Association of angiotensin- converting enzyme gene promoter single nucleotide polymorphisms and haplotype with major depression in a northeastern Thai population. J Renin Angiotensin Aldosterone Syst 2009; 10: 179-184.
14. Mendlewicz J, Oswald P, Claes S, Massat I, Souery D, Van Broeckhoven C et al. Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders. Int J Neuropsychopharmacol 2005; 8: 505-513.
15. Dempster EL, Kiss E, Kapornai K, Daroczi G, Mayer L, Baji I et al. No evidence of an association between two genes, EDN1 and ACE, and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 341-346.
16. Firouzabadi N, Shafiei M, Bahramali E, Ebrahimi SA, Bakhshandeh H, Tajik N. Association of angiotensin-converting enzyme (ACE) gene polymorphism with elevated serum ACE activity and major depression in an Iranian population. Psychiatry Res 2012; 200: 336-342.
17. Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D et al. Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 2011; 16: 516-532.
18. Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 2003; 58: 249-265.
19. Kendler KS, Fiske A, Gardner CO, Gatz M. Delineation of two genetic pathways to major depression. Biol Psychiatry 2009; 65: 808-811.
20. Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 2013; 18: 963-974.
21. Otte C, Hart S, Neylan TC, Marmar CR, Yaffe K, Mohr DC. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005; 30: 80-91.
22. Zhang Z, Xu G, Liu D, Fan X, Zhu W, Liu X. Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a metaanalysis of 50 case-control studies. PLoS One 2012; 7: e46495.
23. Takeuchi F, Yamamoto K, Katsuya T, Sugiyama T, Nabika T, Ohnaka K et al. Reevaluation of the association of seven candidate genes with blood pressure and hypertension: a replication study and meta-analysis with a larger sample size. Hypertens Res 2012; 35: 825-831.
24. Zintzaras E, Raman G, Kitsios G, Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a metaanalysis. Arch Intern Med 2008; 168: 1077-1089.
25. Ritchie K, Artero S, Beluche I, Ancelin ML, Mann A, Dupuy AM et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry 2004; 184: 147-152.
26. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
27. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977; 1: 385-401.
28. Ancelin ML, Carriere I, Boulenger JP, Malafosse A, Stewart R, Cristol JP et al. Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study). Biol Psychiatry 2010; 68: 125-132.
29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
30. Wenquan N, Yue Q, Pingjin G, Dingliang Z. Review: association between angiotensin converting enzyme G2350A polymorphism and hypertension risk: a metaanalysis. J Renin Angiotensin Aldosterone Syst 2011; 12: 8-14.
31. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B et al. Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 2003; 12: 859-867.
32. Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA et al. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol 2005; 162: 305-317.
33. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 2003; 33: 67-72.
34. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
35. Chaudieu I, Beluche I, Norton J, Boulenger JP, Ritchie K, Ancelin ML. Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J Affect Disord 2008; 106: 307-313.
36. Hellhammer DH, Kirschbaum C, Belkien L. Measurement of salivary cortisol under psychological stimulation. In: Hingtgen JN, Hellhammer DH, Huppman G (eds). Adavanced Methods in Psychobiology. Hogrefe: Toronto, 1987, pp 281-289.
37. Thiebaut AC, Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 2004; 23: 3803-3820.
38. Pritchard JK, Przeworski M. Linkage disequilibrium in humans: models and data. Am J Hum Genet 2001; 69: 1-14.
39. Cox R, Bouzekri N, Martin S, Southam L, Hugill A, Golamaully M et al. Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 2002; 11: 2969-2977.
40. Mueller JC. Linkage disequilibrium for different scales and applications. Brief Bioinform 2004; 5: 355-364.
41. Rockman MV, Wray GA. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 2002; 19: 1991-2004.
42. Foy CA, Rice GI, Ossei-Gerning N, Mansfield MW, Grant PJ. Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography. Hum Genet 1997; 100: 420-425.
43. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001; 68: 1139-1148.
44. Fairbrother WG, Yeh RF, Sharp PA, Burge CB. Predictive identification of exonic splicing enhancers in human genes. Science 2002; 297: 1007-1013.
45. Firouzabadi N, Tajik N, Shafiei M, Ebrahimi SA, Bakhshandeh H. Interaction of A-240T and A2350G related genotypes of angiotensin-converting enzyme (ACE) is associated with decreased serum ACE activity and blood pressure in a healthy Iranian population. Eur J Pharmacol 2011; 668: 241-247.
46. Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc 2010; 5: 1564-1573.
47. Levinson DF. The genetics of depression: a review. Biol Psychiatry 2006; 60: 84-92.
48. Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev 2007; 27: 959-985.
49. Lewinsohn PM, Allen NB, Seeley JR, Gotlib IH. First onset versus recurrence of depression: differential processes of psychosocial risk. J Abnorm Psychol 1999; 108: 483-489.
50. Comings DE, MacMurray JP. Molecular heterosis: a review. Mol Genet Metab 2000; 71: 19-31.
51. Seripa D, Franceschi M, Matera MG, Panza F, Kehoe PG, Gravina C et al. Sex differences in the association of apolipoprotein E and angiotensin- converting enzyme gene polymorphisms with healthy aging and longevity: a populationbased study from Southern Italy. J Gerontol A Biol Sci Med Sci 2006; 61: 918-923.
52. Bhatnagar V, O'Connor DT, Schork NJ, Salem RM, Nievergelt CM, Rana BK et al. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. J Hypertens 2007; 25: 2082-2092.
53. Busquets X, MacFarlane NG, Heine-Suner D, Morla M, Torres-Juan L, Iglesias A et al. Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007; 2: 329-334.
54. Haiman CA, Henderson SO, Bretsky P, Kolonel LN, Henderson BE. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 2003; 63: 6984-6987.
55. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M et al. Genomewide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41: 1094-1099.
56. Gormley K, Bevan S, Markus HS. Polymorphisms in genes of the renin-angiotensin system and cerebral small vessel disease. Cerebrovasc Dis 2007; 23: 148-155.
57. Ice GH, Katz-Stein A, Himes J, Kane RL. Diurnal cycles of salivary cortisol in older adults. Psychoneuroendocrinology 2004; 29: 355-370.
58. Jacobs N, Nicolson NA, Derom C, Delespaul P, van Os J, Myin-Germeys I. Electronic monitoring of salivary cortisol sampling compliance in daily life. Life Sci 2005; 76: 2431-2443.
59. Kraemer HC, Giese-Davis J, Yutsis M, O'Hara R, Neri E, Gallagher-Thompson D et al. Design decisions to optimize reliability of daytime cortisol slopes in an older population. Am J Geriatr Psychiatry 2006; 14: 325-333.